Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04743206 · ClinicalTrials.gov registry record · NA

Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device

A NA study, sponsored by University of Florida.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT04743206: Clinical Trial NA study, sponsored by University of Florida.

NCT04743206 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04743206, a NA study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This is a pilot study where the investigators aim to compare initial use of the standard airway clearance device (SACD), most commonly used being High frequency vest airway clearance system (VEST) with subsequent use of a Portable Intra-Pulmonary Percussion Device (PIAPD) in patients with cystic fibrosis (CF) ages 6 -21 years. The primary hypothesis is that there is no effect of PIAPD on Forced expiratory volume in 1 second (FEV1) 2 hours after use, there is no effect on perception of effort and efficacy for the PIAPD. If both are equally effective, the latter device provides an alternative that is both cheaper and portable.

Primary Outcome

oxygen saturation will be obtained by home pulse oximeter device.

Interventions

  • DEVICE Standard Airway Clearance device
  • DEVICE Portable Internal Airway Percussion device

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2021-05-18
Est. Completion 2021-08-01
Phase NA
University of Florida

1,106 total trials

Why NCT04743206 stopped before completion

NCT04743206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Airway Clearance device is the first listed.

NCT04743206 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04743206 about?

NCT04743206 is a clinical study titled "Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device". This is a pilot study where the investigators aim to compare initial use of the standard airway clearance device (SACD), most commonly used being High frequency vest airway clearance system (VEST) with subsequent use of a Portable Intra-Pulmonary Percussion Device (PIAPD) in patients with cystic fib...

What is the current status of trial NCT04743206?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-05-18. Estimated completion is 2021-08-01.

What interventions are being tested in trial NCT04743206?

The interventions under investigation include: Standard Airway Clearance device (DEVICE), Portable Internal Airway Percussion device (DEVICE).

Who is sponsoring clinical trial NCT04743206?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04743206's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04743206, the US trial registry maintained by the National Library of Medicine. NCT04743206 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.